Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells

Cancer Letters

Volumn 383, Issue 2, 2016, Pages 171-182

  Liu, Guoke ^a   Fan, Xiaoyu ^b   Tang, Min ^a   Chen, Rui ^a   Wang, Hao ^a   Jia, Rongjie ^a   Zhou, Xuyu ^c   Jing, Wei ^c   Wang, Huajing ^a   Yang, Yang ^a   Yin, Fan ^d   Wei, Huafeng ^d   Li, Bohua ^a   Zhao, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Autophagy; Chemo resistance; FoxO3a; Osteopontin; Stem like phenotype

Indexed keywords

BAFILOMYCIN A1; CISPLATIN; EPIRUBICIN; OSTEOPONTIN; TRANSCRIPTION FACTOR FKHRL1; VITRONECTIN RECEPTOR; ANTINEOPLASTIC AGENT; FOXO3 PROTEIN, HUMAN; SPP1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER RESISTANCE; CANCER STEM CELL; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; CARCINOMA, HEPATOCELLULAR; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEP-G2 CELL LINE; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; PHENOTYPE; PROTEIN STABILITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FORKHEAD BOX PROTEIN O3; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INTEGRIN ALPHAVBETA3; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS; OSTEOPONTIN; PHENOTYPE; PROTEIN STABILITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84991761861     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.09.033     Document Type: Article

References (49)

1. [1] Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66 (2016), 115–132.
2. [2] Wang, Y., Deng, T., Zeng, L., Chen, W., Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a meta-analysis. Hepatol. Res. 46 (2016), 58–71.
3. [3] Pang, H., Cai, L., Yang, Y., Chen, X., Sui, G., Zhao, C., Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway. Cancer Biother. Radiopharm. 26 (2011), 165–173.
4. [4] Hsieh, I.S., Huang, W.H., Liou, H.C., Chuang, W.J., Yang, R.S., Fu, W.M., Upregulation of drug transporter expression by osteopontin in prostate cancer cells. Mol. Pharmacol. 83 (2013), 968–977.
5. [5] Ye, Q.H., Qin, L.X., Forgues, M., He, P., Kim, J.W., Peng, A.C., et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 9 (2003), 416–423.
6. [6] Luo, J.H., Ren, B., Keryanov, S., Tseng, G.C., Rao, U.N., Monga, S.P., et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44 (2006), 1012–1024.
7. [7] Pietras, A., Katz, A.M., Ekstrom, E.J., Wee, B., Halliday, J.J., Pitter, K.L., et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell 14 (2014), 357–369.
8. [8] Jijiwa, M., Demir, H., Gupta, S., Leung, C., Joshi, K., Orozco, N., et al. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One, 6, 2011, e24217.
9. [9] Todaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 14 (2014), 342–356.
10. [10] Visvader, J.E., Lindeman, G.J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8 (2008), 755–768.
11. [11] Ma, S., Lee, T.K., Zheng, B.J., Chan, K.W., Guan, X.Y., CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27 (2008), 1749–1758.
12. [12] Lee, T.K., Castilho, A., Cheung, V.C., Tang, K.H., Ma, S., Ng, I.O., CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 9 (2011), 50–63.
13. [13] Cao, L., Fan, X., Jing, W., Liang, Y., Chen, R., Liu, Y., et al. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-kappaB-HIF-1alpha pathway. Oncotarget 6 (2015), 6627–6640.
14. [14] Guan, J.L., Simon, A.K., Prescott, M., Menendez, J.A., Liu, F., Wang, F., et al. Autophagy in stem cells. Autophagy 9 (2013), 830–849.
15. [15] Levine, B., Kroemer, G., Autophagy in the pathogenesis of disease. Cell 132 (2008), 27–42.
16. [16] Gong, C., Bauvy, C., Tonelli, G., Yue, W., Delomenie, C., Nicolas, V., et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene 32 (2012), 2261–2272.
17. [17] Bellodi, C., Lidonnici, M.R., Hamilton, A., Helgason, G.V., Soliera, A.R., Ronchetti, M., et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119 (2009), 1109–1123.
18. [18] Rausch, V., Liu, L., Apel, A., Rettig, T., Gladkich, J., Labsch, S., et al. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. J. Pathol. 227 (2012), 325–335.
19. [19] Firat, E., Weyerbrock, A., Gaedicke, S., Grosu, A.L., Niedermann, G., Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells. PLoS One, 7, 2012, e47357.
20. [20] Song, Y.J., Zhang, S.S., Guo, X.L., Sun, K., Han, Z.P., Li, R., et al. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett. 339 (2013), 70–81.
21. [21] Zheng, Y.H., Tian, C., Meng, Y., Qin, Y.W., Du, Y.H., Du, J., et al. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J. Cell Physiol. 227 (2012), 127–135.
22. [22] Mizushima, N., Yoshimori, T., Levine, B., Methods in mammalian autophagy research. Cell 140 (2010), 313–326.
23. [23] Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.A., Outzen, H., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282 (2007), 24131–24145.
24. [24] Shinohara, M.L., Kim, H.J., Kim, J.H., Garcia, V.A., Cantor, H., Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 7235–7239.
25. [25] Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6 (2007), 458–471.
26. [26] Chiacchiera, F., Matrone, A., Ferrari, E., Ingravallo, G., Lo Sasso, G., Murzilli, S., et al. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ. 16 (2009), 1203–1214.
27. [27] Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S., et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 120 (2010), 1043–1055.
28. [28] Van Der Heide, L.P., Hoekman, M.F., Smidt, M.P., The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380 (2004), 297–309.
29. [29] Zhang, L., Li, J., Ouyang, L., Liu, B., Cheng, Y., Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy. Cancer Lett. 373 (2016), 19–26.
30. [30] Romanov, J., Walczak, M., Ibiricu, I., Schuchner, S., Ogris, E., Kraft, C., et al. Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation. EMBO J. 31 (2012), 4304–4317.
31. [31] Shi, G.M., Xu, Y., Fan, J., Zhou, J., Yang, X.R., Qiu, S.J., et al. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J. Cancer Res. Clin. Oncol. 134 (2008), 1155–1163.
32. [32] Pan, H.W., Ou, Y.H., Peng, S.Y., Liu, S.H., Lai, P.L., Lee, P.H., et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98 (2003), 119–127.
33. [33] Sun, B.S., Dong, Q.Z., Ye, Q.H., Sun, H.J., Jia, H.L., Zhu, X.Q., et al. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 48 (2008), 1834–1842.
34. [34] Zhao, J., Dong, L., Lu, B., Wu, G., Xu, D., Chen, J., et al. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 135 (2008), 956–968.
35. [35] Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10 (2006), 51–64.
36. [36] Lazova, R., Camp, R.L., Klump, V., Siddiqui, S.F., Amaravadi, R.K., Pawelek, J.M., Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin. Cancer Res. 18 (2012), 370–379.
37. [37] Mikhaylova, O., Stratton, Y., Hall, D., Kellner, E., Ehmer, B., Drew, A.F., et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 21 (2012), 532–546.
38. [38] Wu, D.H., Jia, C.C., Chen, J., Lin, Z.X., Ruan, D.Y., Li, X., et al. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumour Biol. 35 (2014), 12225–12233.
39. [39] Li, Y., Guo, T., Zhang, Z., Yao, Y., Chang, S., Nor, J.E., et al. Autophagy modulates cell mineralization on fluorapatite-modified scaffolds. J. Dent. Res. 95 (2016), 650–656.
40. [40] Junaid, A., Moon, M.C., Harding, G.E., Zahradka, P., Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. Am. J. Physiol. Cell Physiol. 292 (2007), C919–C926.
41. [41] Rangaswami, H., Bulbule, A., Kundu, G.C., Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 16 (2006), 79–87.
42. [42] Leavenworth, J.W., Verbinnen, B., Yin, J., Huang, H., Cantor, H., A p85alpha-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells. Nat. Immunol. 16 (2015), 96–106.
43. [43] Zhao, K., Zhang, M., Zhang, L., Wang, P., Song, G., Liu, B., et al. Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response. Sci. Rep., 6, 2016, 23771.
44. [44] Natsumeda, M., Maitani, K., Liu, Y., Miyahara, H., Kaur, H., Chu, Q., et al. Targeting Notch signaling and autophagy increases cytotoxicity in glioblastoma neurospheres. Brain Pathol., 2015, 10.1111/bpa.12343 [Epub ahead of print].
45. [45] Yang, H.Z., Ma, Y., Zhou, Y., Xu, L.M., Chen, X.J., Ding, W.B., et al. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Cancer Lett. 361 (2015), 128–136.
46. [46] Yang, M.C., Wang, H.C., Hou, Y.C., Tung, H.L., Chiu, T.J., Shan, Y.S., Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol. Cancer, 14, 2015, 179.
47. [47] Li, J., Yang, B., Zhou, Q., Wu, Y., Shang, D., Guo, Y., et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis 34 (2013), 1343–1351.
48. [48] Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008), 704–715.
49. [49] Bhattacharya, S.D., Mi, Z., Kim, V.M., Guo, H., Talbot, L.J., Kuo, P.C., Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model. Ann. Surg. 255 (2012), 319–325.